Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:59 PM
Ignite Modification Date:
2025-12-24 @ 7:59 PM
NCT ID:
NCT03072004
Eligibility Criteria:
Inclusion criteria:
* leprosy patients;
* patients who show signs of focal demyelinating neuropathy in compression sites of the ulnar and common peroneal nerves by ENM;
* patients with borderline tuberculoid (BT), borderline-borderline (BB), borderline lepromatous (BL) and lepromatous (LL) leprosy forms;
* patients under multidrug therapy (MDT) and;
* (d) patients who live in Uberlândia (Minas Gerais/Brazil).
Exclusion criteria:
* patient diagnosed with other forms of peripheral neuropathies, diagnosed with diabetes and arterial hypertension;
* patient physically disabled;
* patient with cognitive impairment and;
* who refuse to sign a consent form.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
60 Years
Study:
NCT03072004
Study Brief:
Protocol Section:
NCT03072004